Home
Conditions
Monoclonal Gammopathy of Undetermined Significance

Clinical trial condition

Monoclonal Gammopathy of Undetermined Significance

Explore clinical trials studying Monoclonal Gammopathy of Undetermined Significance. Study availability and eligibility vary by location and protocol.

82 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Monoclonal Gammopathy of Undetermined Significance trial results

Enrolling by Invitation

A Study of Carbon 13-based Deep Labelling of Bone Marrow Cells

NCT07057583

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Not Yet Recruiting

Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers

NCT06987708

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging

NCT07624760

Conditions: AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +23 more
Locations: University Hospital Zurich Zurich, Canton of Zurich, Switzerland

View Trial Details

Not Yet Recruiting

Clonal Hematopoiesis of Immunological Significance

NCT05969821

Conditions: Autoimmune Diseases, Autoinflammatory Diseases, Blood Protein Disorders, +27 more
Locations: AP-HP, Service de médecine interne, Hôpital Saint Antoine Paris, France

View Trial Details

Not Yet Recruiting

Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot Study

NCT07305662

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea

View Trial Details

Not Yet Recruiting

Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.

NCT06489613

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies

NCT04702932

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Service de Médecine Interne Paris, France

View Trial Details

Completed

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

NCT04731844

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Genital Diseases, +27 more
Locations: University of Rochester Rochester, New York, United States

View Trial Details

Completed

Imaging in MGUS, SMM and MM

NCT01237054

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss

NCT03951220

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: Churchill Hospital Oxford, Oxfordshire, United Kingdom

View Trial Details

Monoclonal Gammopathy of Undetermined Significance

Monoclonal Gammopathy of Undetermined Significance trial results

Related conditions